{
  "experiment_id": "2edabb556162b77e2c63859b61a74477",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "us.deepseek.r1-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-12-11T04:38:47.564239",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms to more specific terms using the provided Target Schema.\n\nFirst, looking at the \"diagnosis\" field. The input is \"Neurofibromatosis\". The Target Schema's enum for diagnosis includes \"Neurofibromatosis type 1\" but not just \"Neurofibromatosis\". Since \"Neurofibromatosis\" is a general term, and the schema specifies \"Neurofibromatosis type 1\" as an option, I should replace the input with that exact value.\n\nNext, the \"assay\" field has \"DNA sequencing\". The Target Schema's assay enum includes \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", etc. \"DNA sequencing\" is too broad. The most common specific term that matches general DNA sequencing in a clinical context is \"Sanger sequencing\", so I'll use that.\n\nFor \"tumorType\", the input is \"Neurofibroma\". The Target Schema's tumorType enum has several neurofibroma types like \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. The general term \"Neurofibroma\" isn't in the enum, but \"Neurofibroma\" is listed. Wait, checking the enum again: \"Neurofibroma\" is present. Wait, looking at the tumorType enum, yes, \"Neurofibroma\" is an exact option. So maybe the input is already correct. Wait, the input is \"Neurofibroma\" and the enum includes \"Neurofibroma\", so no change needed here. But wait, the user said to narrow broad synonyms. If \"Neurofibroma\" is already in the enum, then it's correct. But maybe the input is a general term and the schema has more specific types. Wait, the input is \"Neurofibroma\", and the schema has \"Neurofibroma\" as an option. So perhaps that's acceptable. But looking at the schema's tumorType enum, there are more specific types like \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. However, if the original data doesn't specify further, we can't assume. Since \"Neurofibroma\" is a valid enum value, we should leave it as is unless the input is a broader term. But \"Neurofibroma\" is already specific enough according to the schema. So no change needed for tumorType.\n\nWait, but the user's instruction says to narrow broad synonyms. If the input uses a term that's already in the Target Schema, then it's correct. So in this case, \"Neurofibroma\" is present in the tumorType enum, so no change. Therefore, only the diagnosis and assay fields need correction.\n\nSo the corrected diagnosis is \"Neurofibromatosis type 1\", assay becomes \"Sanger sequencing\", and tumorType remains \"Neurofibroma\".\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2317,
            "outputTokens": 632,
            "totalTokens": 2949
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "178ba7c7-2ae1-401b-ba7a-4fab86e130d5",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:37:56 GMT",
                "content-type": "application/json",
                "content-length": "2979",
                "connection": "keep-alive",
                "x-amzn-requestid": "178ba7c7-2ae1-401b-ba7a-4fab86e130d5"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms to more specific terms using the provided Target Schema.\n\nFirst, looking at the \"diagnosis\" field. The input is \"Neurofibromatosis\". The Target Schema's enum for diagnosis includes \"Neurofibromatosis type 1\" but not just \"Neurofibromatosis\". Since \"Neurofibromatosis\" is a general term, and the schema specifies \"Neurofibromatosis type 1\" as an option, I should replace the input with that exact value.\n\nNext, the \"assay\" field has \"DNA sequencing\". The Target Schema's assay enum includes \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", etc. \"DNA sequencing\" is too broad. The most common specific term that matches general DNA sequencing in a clinical context is \"Sanger sequencing\", so I'll use that.\n\nFor \"tumorType\", the input is \"Neurofibroma\". The Target Schema's tumorType enum has several neurofibroma types like \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. The general term \"Neurofibroma\" isn't in the enum, but \"Neurofibroma\" is listed. Wait, checking the enum again: \"Neurofibroma\" is present. Wait, looking at the tumorType enum, yes, \"Neurofibroma\" is an exact option. So maybe the input is already correct. Wait, the input is \"Neurofibroma\" and the enum includes \"Neurofibroma\", so no change needed here. But wait, the user said to narrow broad synonyms. If \"Neurofibroma\" is already in the enum, then it's correct. But maybe the input is a general term and the schema has more specific types. Wait, the input is \"Neurofibroma\", and the schema has \"Neurofibroma\" as an option. So perhaps that's acceptable. But looking at the schema's tumorType enum, there are more specific types like \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. However, if the original data doesn't specify further, we can't assume. Since \"Neurofibroma\" is a valid enum value, we should leave it as is unless the input is a broader term. But \"Neurofibroma\" is already specific enough according to the schema. So no change needed for tumorType.\n\nWait, but the user's instruction says to narrow broad synonyms. If the input uses a term that's already in the Target Schema, then it's correct. So in this case, \"Neurofibroma\" is present in the tumorType enum, so no change. Therefore, only the diagnosis and assay fields need correction.\n\nSo the corrected diagnosis is \"Neurofibromatosis type 1\", assay becomes \"Sanger sequencing\", and tumorType remains \"Neurofibroma\".\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2317,
              "outputTokens": 632,
              "totalTokens": 2949
            },
            "metrics": {
              "latencyMs": 3920
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2317,
          "output_tokens": 632,
          "total_tokens": 2949
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```Okay, let's tackle this metadata correction task. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace any broad terms with the more specific ones from the Target Schema.\n\nFirst, the diagnosis is \"NF\". NF could stand for Neurofibromatosis, which has different types. Looking at the Target Schema's diagnosis enum, I see \"Neurofibromatosis type 1\" is an option. Since \"NF\" is too vague, but the most common type is type 1, I'll go with that. However, I should check if there's a more specific term. The schema also has \"NF2-related schwannomatosis\", but without more context, \"Neurofibromatosis type 1\" seems the best fit.\n\nNext, the assay is \"exome sequencing\". The Target Schema's assay enum includes \"whole exome sequencing\". The input uses the abbreviated form, so replacing it with the exact term \"whole exome sequencing\" makes sense.\n\nFor tumorType, the input is \"sarcoma\". The Target Schema's tumorType enum has \"Fibrosarcoma\" and \"Sarcoma\". Since \"Sarcoma\" is a general term and it's present in the enum, but the user wants to narrow it if possible. However, without additional context, \"Sarcoma\" is the most accurate as it's already in the list. Wait, the schema does include \"Sarcoma\" as an option, so no need to change it unless there's a more specific type. Since there's no further info, \"Sarcoma\" stays.\n\nSo the corrected entries should be:\n- Diagnosis: \"Neurofibromatosis type 1\"\n- Assay: \"whole exome sequencing\"\n- TumorType: \"Sarcoma\"\n\nI need to ensure all replacements use the exact terms from the schema. Let me double-check each enum list to confirm. Yes, all the chosen terms are present. No typos, and the structure remains the same as the input.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2314,
            "outputTokens": 453,
            "totalTokens": 2767
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "4e8edd66-b1c3-43ac-8ce4-37c6fe64920f",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:37:59 GMT",
                "content-type": "application/json",
                "content-length": "2166",
                "connection": "keep-alive",
                "x-amzn-requestid": "4e8edd66-b1c3-43ac-8ce4-37c6fe64920f"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace any broad terms with the more specific ones from the Target Schema.\n\nFirst, the diagnosis is \"NF\". NF could stand for Neurofibromatosis, which has different types. Looking at the Target Schema's diagnosis enum, I see \"Neurofibromatosis type 1\" is an option. Since \"NF\" is too vague, but the most common type is type 1, I'll go with that. However, I should check if there's a more specific term. The schema also has \"NF2-related schwannomatosis\", but without more context, \"Neurofibromatosis type 1\" seems the best fit.\n\nNext, the assay is \"exome sequencing\". The Target Schema's assay enum includes \"whole exome sequencing\". The input uses the abbreviated form, so replacing it with the exact term \"whole exome sequencing\" makes sense.\n\nFor tumorType, the input is \"sarcoma\". The Target Schema's tumorType enum has \"Fibrosarcoma\" and \"Sarcoma\". Since \"Sarcoma\" is a general term and it's present in the enum, but the user wants to narrow it if possible. However, without additional context, \"Sarcoma\" is the most accurate as it's already in the list. Wait, the schema does include \"Sarcoma\" as an option, so no need to change it unless there's a more specific type. Since there's no further info, \"Sarcoma\" stays.\n\nSo the corrected entries should be:\n- Diagnosis: \"Neurofibromatosis type 1\"\n- Assay: \"whole exome sequencing\"\n- TumorType: \"Sarcoma\"\n\nI need to ensure all replacements use the exact terms from the schema. Let me double-check each enum list to confirm. Yes, all the chosen terms are present. No typos, and the structure remains the same as the input.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2314,
              "outputTokens": 453,
              "totalTokens": 2767
            },
            "metrics": {
              "latencyMs": 3490
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2314,
          "output_tokens": 453,
          "total_tokens": 2767
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```Okay, let's tackle this metadata correction step by step. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace the broad terms with the specific ones from the Target Schema.\n\nFirst, the diagnosis is \"Neurofibromatoses\". Looking at the Target Schema's diagnosis enum, the closest specific terms are \"Neurofibromatosis type 1\" and others like schwannomatosis types. Since \"Neurofibromatoses\" is a general term that includes several types, but the schema doesn't have that exact term. The most appropriate specific term here would be \"Neurofibromatosis type 1\" because it's a common type and the input might be referring to that. However, if the original data is more general, maybe \"Schwannomatosis-NOS\" (not otherwise specified) could be an option. But given the input is plural, maybe \"Neurofibromatosis type 1\" is the best fit unless there's more context. But wait, the schema has \"Schwannomatosis-NOS\" and \"Schwannomatosis-NEC\". Since \"Neurofibromatoses\" is a broader category that includes NF1, NF2, and schwannomatosis, but the schema doesn't have a general term for all, perhaps the correct approach is to check if \"Neurofibromatosis type 1\" is the intended one. Alternatively, if the input is a general term that doesn't fit any specific, maybe \"Schwannomatosis-NOS\" is better. Hmm, this is a bit tricky. Maybe the user intended to map \"Neurofibromatoses\" to the more specific \"Neurofibromatosis type 1\" as it's a common condition. But I need to be careful. Wait, the Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\", which is specific. Since the input is plural, perhaps the correct term is \"Schwannomatosis-NOS\" because \"Neurofibromatoses\" can refer to multiple types, but the schema doesn't have a general term. Alternatively, maybe the input is a typo and should be mapped to \"Neurofibromatosis type 1\". Without more context, it's safer to choose the most specific possible. Let me check again. The Target Schema's diagnosis enum includes \"Schwannomatosis\", \"Schwannomatosis-NOS\", \"Schwannomatosis-NEC\", and \"Neurofibromatosis type 1\". Since \"Neurofibromatoses\" is a plural term that includes different types, but the schema doesn't have a general term, perhaps the best fit is \"Schwannomatosis-NOS\" as a not otherwise specified category. Alternatively, if the original data is referring to NF1, then \"Neurofibromatosis type 1\" would be correct. But without additional context, I might have to make an educated guess. Let's proceed with \"Neurofibromatosis type 1\" assuming that's the most common type referred to by the general term.\n\nNext, the assay is \"assay by high throughput sequencer\". The Target Schema's assay enum includes \"whole genome sequencing\", \"whole exome sequencing\", \"targeted sequencing\", etc. The term \"high throughput sequencer\" is a method, so the specific assay would depend on the type of sequencing. Since the input is vague, the closest terms in the schema are \"whole genome sequencing\" or \"whole exome sequencing\". However, \"high throughput sequencer\" could also refer to \"next generation targeted sequencing\". Looking at the assay enum, there's \"next generation targeted sequencing\" which might fit. Alternatively, \"whole genome sequencing\" is a high-throughput method. But the input says \"assay by high throughput sequencer\", which is a general term. The schema doesn't have a general term for that, so the best fit would be \"whole genome sequencing\" as a common high-throughput assay. Alternatively, \"targeted sequencing\" if it's targeted. Since the input is vague, maybe \"whole genome sequencing\" is the safest choice. Wait, the assay enum also has \"next generation targeted sequencing\", which specifically mentions next-gen, so that might be more accurate. But the input just says \"high throughput sequencer\", which is a broader term. Hmm. Alternatively, maybe \"genotyping\" if it's for SNP arrays, but that's not exact. The exact terms in the assay enum that relate to sequencing are \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", \"RNA-seq\", etc. Since the input is a general high-throughput sequencing assay, perhaps \"whole genome sequencing\" is the best fit unless more context is given. Alternatively, \"targeted sequencing\" if it's focused. But without more info, \"whole genome sequencing\" is a common high-throughput assay. Alternatively, maybe \"next generation targeted sequencing\" is better. Let me check the Target Schema again. The assay enum includes \"next generation targeted sequencing\" as an option. Since the input is \"assay by high throughput sequencer\", which is a method, the specific assay would be the type of sequencing performed. Since the input is vague, perhaps \"targeted sequencing\" is too specific, and \"whole genome sequencing\" is more general. But the term \"high throughput\" often refers to next-gen methods. So \"next generation targeted sequencing\" might be appropriate if it's targeted, but if it's whole genome, then that. Since the input is not specific, maybe the best approach is to use \"whole genome sequencing\" as the default high-throughput assay. Alternatively, the user might expect \"next generation targeted sequencing\", but I'm not sure. Let's go with \"whole genome sequencing\" for now.\n\nLastly, the tumorType is \"Nerve Sheath Neoplasm\". The Target Schema's tumorType enum includes \"Malignant Peripheral Nerve Sheath Tumor\", \"Atypical Neurofibroma\", \"Schwannoma\", etc. \"Nerve Sheath Neoplasm\" is a broad term that includes MPNST, neurofibromas, schwannomas. The specific terms in the schema would be \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant, or \"Schwannoma\" if it's benign. Since the input is a general term, but the schema doesn't have a general \"Nerve Sheath Neoplasm\", the closest specific term would depend on the type. However, without more context, the safest choice might be \"Malignant Peripheral Nerve Sheath Tumor\" as it's a specific type. Alternatively, \"Schwannoma\" is another possibility. But \"Nerve Sheath Neoplasm\" is a category that includes both benign and malignant tumors. Since the schema doesn't have a general term, perhaps the best fit is \"Malignant Peripheral Nerve Sheath Tumor\" (MPNST) as a specific type. Alternatively, if it's benign, \"Schwannoma\" or \"Neurofibroma\". But without additional info, maybe \"Malignant Peripheral Nerve Sheath Tumor\" is the most precise term that matches the schema. Alternatively, if the tumor is not specified, maybe \"Schwannoma\" is better. Hmm. The input is \"Nerve Sheath Neoplasm\", which is a general term. The schema's tumorType enum includes \"Schwannoma\", \"Neurofibroma\", \"Malignant Peripheral Nerve Sheath Tumor\", etc. Since \"Nerve Sheath Neoplasm\" is a broader category, and the schema requires a specific term, perhaps the correct mapping is \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant, but if not specified, maybe \"Schwannoma\" or \"Neurofibroma\". However, the input doesn't specify malignancy. Since the schema doesn't have a general term, perhaps the best approach is to use \"Schwannoma\" as a common type. Alternatively, \"Neurofibroma\". But without more context, it's hard to choose. Alternatively, maybe \"NF1-Associated Tumor\" if it's related to NF1, but the diagnosis was \"Neurofibromatoses\", which we mapped to \"Neurofibromatosis type 1\". If the diagnosis is NF1, then the tumorType could be \"Neurofibroma\" or \"Plexiform Neurofibroma\". Wait, the diagnosis in the input was \"Neurofibromatoses\", which we mapped to \"Neurofibromatosis type 1\". So if the tumorType is associated with NF1, then \"Neurofibroma\" or \"Plexiform Neurofibroma\" would be appropriate. But the input tumorType is \"Nerve Sheath Neoplasm\", which could be a neurofibroma or schwannoma. Since the diagnosis is now \"Neurofibromatosis type 1\", the tumorType would more likely be a neurofibroma. Looking at the tumorType enum, there's \"Neurofibroma\", \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. The general term here is \"Neurofibroma\". So replacing \"Nerve Sheath Neoplasm\" with \"Neurofibroma\" would make sense in the context of NF1. Alternatively, if it's a malignant tumor, then \"Malignant Peripheral Nerve Sheath Tumor\". But without knowing malignancy, \"Neurofibroma\" is safer. So the corrected tumorType would be \"Neurofibroma\".\n\nPutting it all together:\n\n- Diagnosis: \"Neurofibromatosis type 1\"\n- Assay: \"whole genome sequencing\"\n- TumorType: \"Neurofibroma\"\n\nWait, but earlier I considered the assay might be \"next generation targeted sequencing\". Let me double-check the assay enum. The enum has \"next generation targeted sequencing\" and \"whole genome sequencing\". The input was \"assay by high throughput sequencer\". If the assay is a sequencing assay using high-throughput methods, \"whole genome sequencing\" is a valid choice. Alternatively, if it's targeted, then \"targeted sequencing\" or \"next generation targeted sequencing\". Since the input is vague, perhaps \"whole genome sequencing\" is the best fit. Alternatively, maybe \"genotyping\" if it's for SNPs, but that's not the case here. So I'll stick with \"whole genome sequencing\".\n\nBut wait, the assay enum also includes \"whole exome sequencing\", \"RNA-seq\", etc. The term \"high throughput sequencer\" is a method, so the assay would be the specific application. Since the input doesn't specify the type, maybe the correct term is \"whole genome sequencing\" as a common high-throughput assay. Alternatively, the user might have intended \"targeted sequencing\", but without more info, \"whole genome sequencing\" is a safe choice.\n\nAlternatively, maybe the assay is \"next generation targeted sequencing\" which is in the enum. But \"high throughput sequencer\" is a method, not the assay name. The assay would be the specific type of sequencing performed. Since the input is vague, perhaps the best approach is to use \"whole genome sequencing\" as it's a common high-throughput assay. So I'll go with that.\n\nFinal corrections:\n\n- diagnosis: \"Neurofibromatosis type 1\"\n- assay: \"whole genome sequencing\"\n- tumorType: \"Neurofibroma\"\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2325,
            "outputTokens": 2366,
            "totalTokens": 4691
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "0ac44622-a891-490c-a888-99f905e7f41c",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:13 GMT",
                "content-type": "application/json",
                "content-length": "10768",
                "connection": "keep-alive",
                "x-amzn-requestid": "0ac44622-a891-490c-a888-99f905e7f41c"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction step by step. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace the broad terms with the specific ones from the Target Schema.\n\nFirst, the diagnosis is \"Neurofibromatoses\". Looking at the Target Schema's diagnosis enum, the closest specific terms are \"Neurofibromatosis type 1\" and others like schwannomatosis types. Since \"Neurofibromatoses\" is a general term that includes several types, but the schema doesn't have that exact term. The most appropriate specific term here would be \"Neurofibromatosis type 1\" because it's a common type and the input might be referring to that. However, if the original data is more general, maybe \"Schwannomatosis-NOS\" (not otherwise specified) could be an option. But given the input is plural, maybe \"Neurofibromatosis type 1\" is the best fit unless there's more context. But wait, the schema has \"Schwannomatosis-NOS\" and \"Schwannomatosis-NEC\". Since \"Neurofibromatoses\" is a broader category that includes NF1, NF2, and schwannomatosis, but the schema doesn't have a general term for all, perhaps the correct approach is to check if \"Neurofibromatosis type 1\" is the intended one. Alternatively, if the input is a general term that doesn't fit any specific, maybe \"Schwannomatosis-NOS\" is better. Hmm, this is a bit tricky. Maybe the user intended to map \"Neurofibromatoses\" to the more specific \"Neurofibromatosis type 1\" as it's a common condition. But I need to be careful. Wait, the Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\", which is specific. Since the input is plural, perhaps the correct term is \"Schwannomatosis-NOS\" because \"Neurofibromatoses\" can refer to multiple types, but the schema doesn't have a general term. Alternatively, maybe the input is a typo and should be mapped to \"Neurofibromatosis type 1\". Without more context, it's safer to choose the most specific possible. Let me check again. The Target Schema's diagnosis enum includes \"Schwannomatosis\", \"Schwannomatosis-NOS\", \"Schwannomatosis-NEC\", and \"Neurofibromatosis type 1\". Since \"Neurofibromatoses\" is a plural term that includes different types, but the schema doesn't have a general term, perhaps the best fit is \"Schwannomatosis-NOS\" as a not otherwise specified category. Alternatively, if the original data is referring to NF1, then \"Neurofibromatosis type 1\" would be correct. But without additional context, I might have to make an educated guess. Let's proceed with \"Neurofibromatosis type 1\" assuming that's the most common type referred to by the general term.\n\nNext, the assay is \"assay by high throughput sequencer\". The Target Schema's assay enum includes \"whole genome sequencing\", \"whole exome sequencing\", \"targeted sequencing\", etc. The term \"high throughput sequencer\" is a method, so the specific assay would depend on the type of sequencing. Since the input is vague, the closest terms in the schema are \"whole genome sequencing\" or \"whole exome sequencing\". However, \"high throughput sequencer\" could also refer to \"next generation targeted sequencing\". Looking at the assay enum, there's \"next generation targeted sequencing\" which might fit. Alternatively, \"whole genome sequencing\" is a high-throughput method. But the input says \"assay by high throughput sequencer\", which is a general term. The schema doesn't have a general term for that, so the best fit would be \"whole genome sequencing\" as a common high-throughput assay. Alternatively, \"targeted sequencing\" if it's targeted. Since the input is vague, maybe \"whole genome sequencing\" is the safest choice. Wait, the assay enum also has \"next generation targeted sequencing\", which specifically mentions next-gen, so that might be more accurate. But the input just says \"high throughput sequencer\", which is a broader term. Hmm. Alternatively, maybe \"genotyping\" if it's for SNP arrays, but that's not exact. The exact terms in the assay enum that relate to sequencing are \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", \"RNA-seq\", etc. Since the input is a general high-throughput sequencing assay, perhaps \"whole genome sequencing\" is the best fit unless more context is given. Alternatively, \"targeted sequencing\" if it's focused. But without more info, \"whole genome sequencing\" is a common high-throughput assay. Alternatively, maybe \"next generation targeted sequencing\" is better. Let me check the Target Schema again. The assay enum includes \"next generation targeted sequencing\" as an option. Since the input is \"assay by high throughput sequencer\", which is a method, the specific assay would be the type of sequencing performed. Since the input is vague, perhaps \"targeted sequencing\" is too specific, and \"whole genome sequencing\" is more general. But the term \"high throughput\" often refers to next-gen methods. So \"next generation targeted sequencing\" might be appropriate if it's targeted, but if it's whole genome, then that. Since the input is not specific, maybe the best approach is to use \"whole genome sequencing\" as the default high-throughput assay. Alternatively, the user might expect \"next generation targeted sequencing\", but I'm not sure. Let's go with \"whole genome sequencing\" for now.\n\nLastly, the tumorType is \"Nerve Sheath Neoplasm\". The Target Schema's tumorType enum includes \"Malignant Peripheral Nerve Sheath Tumor\", \"Atypical Neurofibroma\", \"Schwannoma\", etc. \"Nerve Sheath Neoplasm\" is a broad term that includes MPNST, neurofibromas, schwannomas. The specific terms in the schema would be \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant, or \"Schwannoma\" if it's benign. Since the input is a general term, but the schema doesn't have a general \"Nerve Sheath Neoplasm\", the closest specific term would depend on the type. However, without more context, the safest choice might be \"Malignant Peripheral Nerve Sheath Tumor\" as it's a specific type. Alternatively, \"Schwannoma\" is another possibility. But \"Nerve Sheath Neoplasm\" is a category that includes both benign and malignant tumors. Since the schema doesn't have a general term, perhaps the best fit is \"Malignant Peripheral Nerve Sheath Tumor\" (MPNST) as a specific type. Alternatively, if it's benign, \"Schwannoma\" or \"Neurofibroma\". But without additional info, maybe \"Malignant Peripheral Nerve Sheath Tumor\" is the most precise term that matches the schema. Alternatively, if the tumor is not specified, maybe \"Schwannoma\" is better. Hmm. The input is \"Nerve Sheath Neoplasm\", which is a general term. The schema's tumorType enum includes \"Schwannoma\", \"Neurofibroma\", \"Malignant Peripheral Nerve Sheath Tumor\", etc. Since \"Nerve Sheath Neoplasm\" is a broader category, and the schema requires a specific term, perhaps the correct mapping is \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant, but if not specified, maybe \"Schwannoma\" or \"Neurofibroma\". However, the input doesn't specify malignancy. Since the schema doesn't have a general term, perhaps the best approach is to use \"Schwannoma\" as a common type. Alternatively, \"Neurofibroma\". But without more context, it's hard to choose. Alternatively, maybe \"NF1-Associated Tumor\" if it's related to NF1, but the diagnosis was \"Neurofibromatoses\", which we mapped to \"Neurofibromatosis type 1\". If the diagnosis is NF1, then the tumorType could be \"Neurofibroma\" or \"Plexiform Neurofibroma\". Wait, the diagnosis in the input was \"Neurofibromatoses\", which we mapped to \"Neurofibromatosis type 1\". So if the tumorType is associated with NF1, then \"Neurofibroma\" or \"Plexiform Neurofibroma\" would be appropriate. But the input tumorType is \"Nerve Sheath Neoplasm\", which could be a neurofibroma or schwannoma. Since the diagnosis is now \"Neurofibromatosis type 1\", the tumorType would more likely be a neurofibroma. Looking at the tumorType enum, there's \"Neurofibroma\", \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. The general term here is \"Neurofibroma\". So replacing \"Nerve Sheath Neoplasm\" with \"Neurofibroma\" would make sense in the context of NF1. Alternatively, if it's a malignant tumor, then \"Malignant Peripheral Nerve Sheath Tumor\". But without knowing malignancy, \"Neurofibroma\" is safer. So the corrected tumorType would be \"Neurofibroma\".\n\nPutting it all together:\n\n- Diagnosis: \"Neurofibromatosis type 1\"\n- Assay: \"whole genome sequencing\"\n- TumorType: \"Neurofibroma\"\n\nWait, but earlier I considered the assay might be \"next generation targeted sequencing\". Let me double-check the assay enum. The enum has \"next generation targeted sequencing\" and \"whole genome sequencing\". The input was \"assay by high throughput sequencer\". If the assay is a sequencing assay using high-throughput methods, \"whole genome sequencing\" is a valid choice. Alternatively, if it's targeted, then \"targeted sequencing\" or \"next generation targeted sequencing\". Since the input is vague, perhaps \"whole genome sequencing\" is the best fit. Alternatively, maybe \"genotyping\" if it's for SNPs, but that's not the case here. So I'll stick with \"whole genome sequencing\".\n\nBut wait, the assay enum also includes \"whole exome sequencing\", \"RNA-seq\", etc. The term \"high throughput sequencer\" is a method, so the assay would be the specific application. Since the input doesn't specify the type, maybe the correct term is \"whole genome sequencing\" as a common high-throughput assay. Alternatively, the user might have intended \"targeted sequencing\", but without more info, \"whole genome sequencing\" is a safe choice.\n\nAlternatively, maybe the assay is \"next generation targeted sequencing\" which is in the enum. But \"high throughput sequencer\" is a method, not the assay name. The assay would be the specific type of sequencing performed. Since the input is vague, perhaps the best approach is to use \"whole genome sequencing\" as it's a common high-throughput assay. So I'll go with that.\n\nFinal corrections:\n\n- diagnosis: \"Neurofibromatosis type 1\"\n- assay: \"whole genome sequencing\"\n- tumorType: \"Neurofibroma\"\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2325,
              "outputTokens": 2366,
              "totalTokens": 4691
            },
            "metrics": {
              "latencyMs": 13686
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2325,
          "output_tokens": 2366,
          "total_tokens": 4691
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms in the input data using the exact terms from the Target Schema.\n\nFirst, looking at the \"diagnosis\" field. The input is \"neurocutaneous syndrome\". The Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\" and others. Since \"neurocutaneous syndrome\" is a broad term that includes conditions like Neurofibromatosis, but the schema doesn't have that exact term. The closest specific term under neurocutaneous disorders here would be \"Neurofibromatosis type 1\", but I need to check if that's the correct mapping. However, the user might be referring to a different condition. Wait, the schema has \"Schwannomatosis\" and related terms, but \"neurocutaneous syndrome\" is a broader category. Since there's no exact match, maybe \"Schwannomatosis-NOS\" (Not Otherwise Specified) is a better fit, but I'm not sure. Alternatively, \"Unknown\" if it's unclear. But the original input might be a general term that needs to map to a more specific one in the schema. Alternatively, maybe \"Neurofibromatosis type 1\" is the intended specific term here. Hmm, but without more context, it's safer to go with \"Unknown\" if there's no direct match. Wait, the Target Schema's diagnosis enum doesn't include \"neurocutaneous syndrome\", so the correct approach is to replace the broad term with the most specific possible from the schema. Since \"neurocutaneous syndrome\" can include several conditions like Neurofibromatosis type 1, but the input might not specify which one. If the original data is \"neurocutaneous syndrome\" and the schema doesn't have that, perhaps the correct term is \"Unknown\" or \"Not Applicable\". But maybe the user intended to map it to a specific condition. Alternatively, maybe \"Schwannomatosis-NOS\" is a possibility. But I'm not certain. Let me check the schema again. The diagnosis enum includes \"Neurofibromatosis type 1\", \"Noonan Syndrome\", \"Schwannomatosis\", etc. Since \"neurocutaneous syndrome\" is a broader term that includes NF1 and others, but the exact term isn't present, perhaps the correct replacement is \"Neurofibromatosis type 1\" if that's the most common condition under that category. Alternatively, if it's a schwannomatosis case, maybe \"Schwannomatosis-NOS\". But without additional context, it's hard to tell. The safest choice here might be \"Unknown\" since the original term isn't in the schema. However, the user might expect a more specific term. Alternatively, maybe \"Schwannomatosis-NOS\" is the intended replacement. Wait, the Target Schema has \"Schwannomatosis-NOS\" which is \"Not Otherwise Specified\". If the original diagnosis is a type of schwannomatosis but not specified, that would fit. But \"neurocutaneous syndrome\" is a broader term that includes other conditions like neurofibromatosis. So perhaps \"Neurofibromatosis type 1\" is the correct mapping here. But I'm not entirely sure. Maybe the user intended to map \"neurocutaneous syndrome\" to a specific condition in the schema. Since \"Neurofibromatosis type 1\" is part of neurocutaneous syndromes, that might be the best fit. Let's go with that.\n\nNext, the \"assay\" field is \"spectroscopy\". The Target Schema's assay enum includes \"FTIR spectroscopy\", \"magnetic resonance spectroscopy\", etc. The input is a general term, so needs to be narrowed. The schema has \"FTIR spectroscopy\" and \"magnetic resonance spectroscopy\". Without more context, it's hard to choose. But \"FTIR spectroscopy\" is a specific type. However, if the original assay is a different type, like NMR or another spectroscopy, but since the schema doesn't have those, maybe the best fit is \"FTIR spectroscopy\" as it's listed. Alternatively, if it's magnetic resonance, then \"magnetic resonance spectroscopy\". But without more info, perhaps the correct approach is to pick the most common or the one that matches the term. The input is \"spectroscopy\", which is too broad. The schema requires a specific type. Since \"FTIR spectroscopy\" is an option, but maybe the correct term is \"magnetic resonance spectroscopy\" if it's related to MRI. Alternatively, if it's another type, but since the schema doesn't have a general \"spectroscopy\", the user must pick from the available options. Since the input is just \"spectroscopy\", and the Target Schema doesn't have a general term, perhaps the best choice is \"FTIR spectroscopy\" as the first option. Alternatively, maybe the assay is part of another method, but without context, I'll have to choose the closest. Wait, the Target Schema's assay enum also includes \"mass spectrometry\", but that's different. So, the input \"spectroscopy\" needs to be mapped to a specific type. Since \"FTIR spectroscopy\" is an option, that's the correct replacement.\n\nLastly, the \"tumorType\" is \"unknown\". The Target Schema's tumorType enum includes \"Unknown\", so that's already correct. No change needed here.\n\nSo, the corrected metadata would be:\n- diagnosis: \"Neurofibromatosis type 1\" (assuming that's the intended specific term)\n- assay: \"FTIR spectroscopy\"\n- tumorType: \"Unknown\"\n\nBut wait, maybe \"neurocutaneous syndrome\" should map to \"Schwannomatosis-NOS\" or another term. Alternatively, if the original data's diagnosis is not specific enough, perhaps \"Unknown\" is more appropriate. However, the instruction says to narrow broad synonyms to more specific terms. Since \"neurocutaneous syndrome\" is a broad term that includes several specific diagnoses, but the schema doesn't have a direct equivalent, the correct approach is to choose the most specific possible term from the schema. If \"Neurofibromatosis type 1\" is a type of neurocutaneous syndrome, then that's a valid narrowing. Alternatively, if the original data is a schwannomatosis case, then \"Schwannomatosis-NOS\". But without additional context, it's challenging. The user might expect the assistant to make the best possible match. Given that \"Neurofibromatosis type 1\" is a common neurocutaneous disorder, that's a plausible replacement. Alternatively, if the input is a placeholder, maybe \"Unknown\" is better. But the instruction says to narrow, so replacing with a specific term is better. I'll proceed with \"Neurofibromatosis type 1\".\n\nFor the assay, \"spectroscopy\" to \"FTIR spectroscopy\" as it's the specific type in the schema.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2314,
            "outputTokens": 1442,
            "totalTokens": 3756
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "6051a237-40c0-4aee-bd70-107eed85384d",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:22 GMT",
                "content-type": "application/json",
                "content-length": "6819",
                "connection": "keep-alive",
                "x-amzn-requestid": "6051a237-40c0-4aee-bd70-107eed85384d"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms in the input data using the exact terms from the Target Schema.\n\nFirst, looking at the \"diagnosis\" field. The input is \"neurocutaneous syndrome\". The Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\" and others. Since \"neurocutaneous syndrome\" is a broad term that includes conditions like Neurofibromatosis, but the schema doesn't have that exact term. The closest specific term under neurocutaneous disorders here would be \"Neurofibromatosis type 1\", but I need to check if that's the correct mapping. However, the user might be referring to a different condition. Wait, the schema has \"Schwannomatosis\" and related terms, but \"neurocutaneous syndrome\" is a broader category. Since there's no exact match, maybe \"Schwannomatosis-NOS\" (Not Otherwise Specified) is a better fit, but I'm not sure. Alternatively, \"Unknown\" if it's unclear. But the original input might be a general term that needs to map to a more specific one in the schema. Alternatively, maybe \"Neurofibromatosis type 1\" is the intended specific term here. Hmm, but without more context, it's safer to go with \"Unknown\" if there's no direct match. Wait, the Target Schema's diagnosis enum doesn't include \"neurocutaneous syndrome\", so the correct approach is to replace the broad term with the most specific possible from the schema. Since \"neurocutaneous syndrome\" can include several conditions like Neurofibromatosis type 1, but the input might not specify which one. If the original data is \"neurocutaneous syndrome\" and the schema doesn't have that, perhaps the correct term is \"Unknown\" or \"Not Applicable\". But maybe the user intended to map it to a specific condition. Alternatively, maybe \"Schwannomatosis-NOS\" is a possibility. But I'm not certain. Let me check the schema again. The diagnosis enum includes \"Neurofibromatosis type 1\", \"Noonan Syndrome\", \"Schwannomatosis\", etc. Since \"neurocutaneous syndrome\" is a broader term that includes NF1 and others, but the exact term isn't present, perhaps the correct replacement is \"Neurofibromatosis type 1\" if that's the most common condition under that category. Alternatively, if it's a schwannomatosis case, maybe \"Schwannomatosis-NOS\". But without additional context, it's hard to tell. The safest choice here might be \"Unknown\" since the original term isn't in the schema. However, the user might expect a more specific term. Alternatively, maybe \"Schwannomatosis-NOS\" is the intended replacement. Wait, the Target Schema has \"Schwannomatosis-NOS\" which is \"Not Otherwise Specified\". If the original diagnosis is a type of schwannomatosis but not specified, that would fit. But \"neurocutaneous syndrome\" is a broader term that includes other conditions like neurofibromatosis. So perhaps \"Neurofibromatosis type 1\" is the correct mapping here. But I'm not entirely sure. Maybe the user intended to map \"neurocutaneous syndrome\" to a specific condition in the schema. Since \"Neurofibromatosis type 1\" is part of neurocutaneous syndromes, that might be the best fit. Let's go with that.\n\nNext, the \"assay\" field is \"spectroscopy\". The Target Schema's assay enum includes \"FTIR spectroscopy\", \"magnetic resonance spectroscopy\", etc. The input is a general term, so needs to be narrowed. The schema has \"FTIR spectroscopy\" and \"magnetic resonance spectroscopy\". Without more context, it's hard to choose. But \"FTIR spectroscopy\" is a specific type. However, if the original assay is a different type, like NMR or another spectroscopy, but since the schema doesn't have those, maybe the best fit is \"FTIR spectroscopy\" as it's listed. Alternatively, if it's magnetic resonance, then \"magnetic resonance spectroscopy\". But without more info, perhaps the correct approach is to pick the most common or the one that matches the term. The input is \"spectroscopy\", which is too broad. The schema requires a specific type. Since \"FTIR spectroscopy\" is an option, but maybe the correct term is \"magnetic resonance spectroscopy\" if it's related to MRI. Alternatively, if it's another type, but since the schema doesn't have a general \"spectroscopy\", the user must pick from the available options. Since the input is just \"spectroscopy\", and the Target Schema doesn't have a general term, perhaps the best choice is \"FTIR spectroscopy\" as the first option. Alternatively, maybe the assay is part of another method, but without context, I'll have to choose the closest. Wait, the Target Schema's assay enum also includes \"mass spectrometry\", but that's different. So, the input \"spectroscopy\" needs to be mapped to a specific type. Since \"FTIR spectroscopy\" is an option, that's the correct replacement.\n\nLastly, the \"tumorType\" is \"unknown\". The Target Schema's tumorType enum includes \"Unknown\", so that's already correct. No change needed here.\n\nSo, the corrected metadata would be:\n- diagnosis: \"Neurofibromatosis type 1\" (assuming that's the intended specific term)\n- assay: \"FTIR spectroscopy\"\n- tumorType: \"Unknown\"\n\nBut wait, maybe \"neurocutaneous syndrome\" should map to \"Schwannomatosis-NOS\" or another term. Alternatively, if the original data's diagnosis is not specific enough, perhaps \"Unknown\" is more appropriate. However, the instruction says to narrow broad synonyms to more specific terms. Since \"neurocutaneous syndrome\" is a broad term that includes several specific diagnoses, but the schema doesn't have a direct equivalent, the correct approach is to choose the most specific possible term from the schema. If \"Neurofibromatosis type 1\" is a type of neurocutaneous syndrome, then that's a valid narrowing. Alternatively, if the original data is a schwannomatosis case, then \"Schwannomatosis-NOS\". But without additional context, it's challenging. The user might expect the assistant to make the best possible match. Given that \"Neurofibromatosis type 1\" is a common neurocutaneous disorder, that's a plausible replacement. Alternatively, if the input is a placeholder, maybe \"Unknown\" is better. But the instruction says to narrow, so replacing with a specific term is better. I'll proceed with \"Neurofibromatosis type 1\".\n\nFor the assay, \"spectroscopy\" to \"FTIR spectroscopy\" as it's the specific type in the schema.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2314,
              "outputTokens": 1442,
              "totalTokens": 3756
            },
            "metrics": {
              "latencyMs": 8862
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2314,
          "output_tokens": 1442,
          "total_tokens": 3756
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```Okay, let's tackle this metadata correction task. The goal is to replace broad synonyms with more specific terms from the Target Schema. Let's look at each field in the input data.\n\nFirst, the \"diagnosis\" is \"Not Applicable\". Checking the enum list for diagnosis, \"Not Applicable\" is already an exact match. So no change needed here.\n\nNext, the \"assay\" is \"immunoassay\". The Target Schema's assay enum includes \"immunoassay\" as a valid value. Since it's already present, this doesn't need narrowing. Wait, but I should double-check if \"immunoassay\" is considered a broad term here. The schema lists it as an allowed value, so maybe it's acceptable. However, sometimes \"immunoassay\" can be a general term, but in this context, if the schema includes it, we should leave it as is. So no change here either.\n\nNow, the \"tumorType\" is \"neurofibroma\". Looking at the tumorType enum, there are several specific types of neurofibroma listed: \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", \"Cutaneous Neurofibroma\", etc. The input just says \"neurofibroma\", which is a general term. The Target Schema has \"Neurofibroma\" as an option. Wait, checking the enum list again: \"Neurofibroma\" is present. So the input \"neurofibroma\" is lowercase, but the schema uses title case. The instructions say to use exact values. So the correct value should be \"Neurofibroma\" with a capital N. Therefore, the tumorType should be corrected to \"Neurofibroma\" to match the exact enum value.\n\nWait, but the input's tumorType is \"neurofibroma\" in lowercase, and the schema's enum has \"Neurofibroma\" with a capital N. Since the schema requires exact values, including capitalization, the correction here is to capitalize the first letter. So the tumorType should be \"Neurofibroma\".\n\nSo the final corrected JSON should have \"Neurofibroma\" for tumorType, and the other fields remain the same since they already match the schema's enums.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2317,
            "outputTokens": 487,
            "totalTokens": 2804
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "ab6f197c-2fe7-456b-a8c4-066339df3af6",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:25 GMT",
                "content-type": "application/json",
                "content-length": "2347",
                "connection": "keep-alive",
                "x-amzn-requestid": "ab6f197c-2fe7-456b-a8c4-066339df3af6"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The goal is to replace broad synonyms with more specific terms from the Target Schema. Let's look at each field in the input data.\n\nFirst, the \"diagnosis\" is \"Not Applicable\". Checking the enum list for diagnosis, \"Not Applicable\" is already an exact match. So no change needed here.\n\nNext, the \"assay\" is \"immunoassay\". The Target Schema's assay enum includes \"immunoassay\" as a valid value. Since it's already present, this doesn't need narrowing. Wait, but I should double-check if \"immunoassay\" is considered a broad term here. The schema lists it as an allowed value, so maybe it's acceptable. However, sometimes \"immunoassay\" can be a general term, but in this context, if the schema includes it, we should leave it as is. So no change here either.\n\nNow, the \"tumorType\" is \"neurofibroma\". Looking at the tumorType enum, there are several specific types of neurofibroma listed: \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", \"Cutaneous Neurofibroma\", etc. The input just says \"neurofibroma\", which is a general term. The Target Schema has \"Neurofibroma\" as an option. Wait, checking the enum list again: \"Neurofibroma\" is present. So the input \"neurofibroma\" is lowercase, but the schema uses title case. The instructions say to use exact values. So the correct value should be \"Neurofibroma\" with a capital N. Therefore, the tumorType should be corrected to \"Neurofibroma\" to match the exact enum value.\n\nWait, but the input's tumorType is \"neurofibroma\" in lowercase, and the schema's enum has \"Neurofibroma\" with a capital N. Since the schema requires exact values, including capitalization, the correction here is to capitalize the first letter. So the tumorType should be \"Neurofibroma\".\n\nSo the final corrected JSON should have \"Neurofibroma\" for tumorType, and the other fields remain the same since they already match the schema's enums.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2317,
              "outputTokens": 487,
              "totalTokens": 2804
            },
            "metrics": {
              "latencyMs": 3410
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2317,
          "output_tokens": 487,
          "total_tokens": 2804
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FLIPR high-throughput cellular screening\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation:**\n1. Diagnosis: \"neurofibromatosis\" was narrowed to \"Neurofibromatosis type 1\" (the most specific matching term in the schema)\n2. Assay: \"plate based reporter assay\" was mapped to \"FLIPR high-throughput cellular screening\" (the schema's term for plate-based cellular screening assays)\n3. TumorType: \"benign neurofibroma\" was narrowed to \"Neurofibroma\" (the base term in the schema since \"benign\" is implied in this classification and no more specific matching subtype exists in the enum)Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms to specific terms from the Target Schema. Let's start with each field one by one.\n\nFirst, the diagnosis is \"neurofibromatosis\". The Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\" and \"Schwannomatosis\" among others. Since \"neurofibromatosis\" is a general term, I need to find the most specific match. The input doesn't specify type 1 or 2, but \"Neurofibromatosis type 1\" is a controlled term. So I'll replace \"neurofibromatosis\" with \"Neurofibromatosis type 1\".\n\nNext, the assay is \"plate based reporter assay\". Looking at the assay enum, there's \"FLIPR high-throughput cellular screening\". FLIPR assays are plate-based and used for reporter gene assays, so this seems like the correct specific term. The original term is a broad description, so replacing it with the exact enum value makes sense.\n\nFor tumorType, the input is \"benign neurofibroma\". The Target Schema's tumorType enum has \"Neurofibroma\" and subtypes like \"Cutaneous Neurofibroma\" or \"Plexiform Neurofibroma\". Since \"benign neurofibroma\" is a general term and the schema doesn't have a \"benign\" qualifier, the closest exact match is \"Neurofibroma\". The schema includes \"Atypical Neurofibroma\" and others, but \"benign\" isn't specified, so the base term is appropriate here.\n\nI need to ensure all replacements use the exact enum values. No variations allowed. Let me double-check each term against the schema to confirm. Yes, \"Neurofibromatosis type 1\", \"FLIPR high-throughput cellular screening\", and \"Neurofibroma\" are all present. That should be correct.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2321,
            "outputTokens": 555,
            "totalTokens": 2876
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "090793be-226a-4716-8f0b-8951cbf9f9f4",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:29 GMT",
                "content-type": "application/json",
                "content-length": "2637",
                "connection": "keep-alive",
                "x-amzn-requestid": "090793be-226a-4716-8f0b-8951cbf9f9f4"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FLIPR high-throughput cellular screening\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation:**\n1. Diagnosis: \"neurofibromatosis\" was narrowed to \"Neurofibromatosis type 1\" (the most specific matching term in the schema)\n2. Assay: \"plate based reporter assay\" was mapped to \"FLIPR high-throughput cellular screening\" (the schema's term for plate-based cellular screening assays)\n3. TumorType: \"benign neurofibroma\" was narrowed to \"Neurofibroma\" (the base term in the schema since \"benign\" is implied in this classification and no more specific matching subtype exists in the enum)"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms to specific terms from the Target Schema. Let's start with each field one by one.\n\nFirst, the diagnosis is \"neurofibromatosis\". The Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\" and \"Schwannomatosis\" among others. Since \"neurofibromatosis\" is a general term, I need to find the most specific match. The input doesn't specify type 1 or 2, but \"Neurofibromatosis type 1\" is a controlled term. So I'll replace \"neurofibromatosis\" with \"Neurofibromatosis type 1\".\n\nNext, the assay is \"plate based reporter assay\". Looking at the assay enum, there's \"FLIPR high-throughput cellular screening\". FLIPR assays are plate-based and used for reporter gene assays, so this seems like the correct specific term. The original term is a broad description, so replacing it with the exact enum value makes sense.\n\nFor tumorType, the input is \"benign neurofibroma\". The Target Schema's tumorType enum has \"Neurofibroma\" and subtypes like \"Cutaneous Neurofibroma\" or \"Plexiform Neurofibroma\". Since \"benign neurofibroma\" is a general term and the schema doesn't have a \"benign\" qualifier, the closest exact match is \"Neurofibroma\". The schema includes \"Atypical Neurofibroma\" and others, but \"benign\" isn't specified, so the base term is appropriate here.\n\nI need to ensure all replacements use the exact enum values. No variations allowed. Let me double-check each term against the schema to confirm. Yes, \"Neurofibromatosis type 1\", \"FLIPR high-throughput cellular screening\", and \"Neurofibroma\" are all present. That should be correct.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2321,
              "outputTokens": 555,
              "totalTokens": 2876
            },
            "metrics": {
              "latencyMs": 3276
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2321,
          "output_tokens": 555,
          "total_tokens": 2876
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Unknown\"\n}\n``` \n\n**Explanation:**  \n- **Diagnosis:** \"RASopathy\" was replaced with \"Noonan Syndrome\" (a specific RASopathy disorder in the target schema)  \n- **Assay:** \"immunoassay\" already matches the exact controlled terminology  \n- **TumorType:** \"NFIB\" (not in target schema) was mapped to \"Unknown\" since no valid narrower term exists in the controlled vocabularyOkay, let's tackle this metadata correction task. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace any broad terms with the more specific ones from the Target Schema.\n\nFirst, the diagnosis is \"RASopathy\". Looking at the Target Schema's diagnosis enum, I don't see \"RASopathy\" listed. However, I know that Noonan Syndrome is a type of RASopathy. So, replacing \"RASopathy\" with \"Noonan Syndrome\" makes sense here. That's one of the allowed values, so that's a good substitution.\n\nNext, the assay is \"immunoassay\". Checking the assay enum, \"immunoassay\" is actually present. So no changes needed here. It's already using the exact term from the schema.\n\nThen, the tumorType is \"NFIB\". The Target Schema's tumorType enum doesn't have \"NFIB\". I need to think about what \"NFIB\" refers to. NFIB is a gene, but in the context of tumor types, maybe it's a typo or abbreviation. Looking at the options, \"NF1-Associated Tumor\" or \"NF2-Associated Tumor\" might be relevant. Since the diagnosis was RASopathy (now Noonan Syndrome), but the original input's tumorType is \"NFIB\", which isn't in the schema. Since \"NFIB\" isn't listed, the safest choice from the enum is \"Unknown\" because there's no direct match. Alternatively, if \"NFIB\" is a specific tumor type not listed, but according to the schema, \"Unknown\" is an option. So I'll go with \"Unknown\" for tumorType.\n\nWait, but maybe \"NFIB\" is a type of neurofibroma? Let me check the tumorType enum again. There's \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", etc. But \"NFIB\" isn't there. So unless \"NFIB\" is a known abbreviation for one of the listed types, which I don't think it is, \"Unknown\" is the correct choice here.\n\nSo the corrected metadata would be:\n- diagnosis: \"Noonan Syndrome\"\n- assay: remains \"immunoassay\"\n- tumorType: \"Unknown\"\n\nI need to make sure all replacements are exact matches from the Target Schema. Since \"Noonan Syndrome\" and \"Unknown\" are in the enums, and \"immunoassay\" is already correct, this should be the right answer.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2316,
            "outputTokens": 632,
            "totalTokens": 2948
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "9d31dde9-a924-4526-b8b4-0bb691eb11c3",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:33 GMT",
                "content-type": "application/json",
                "content-length": "2869",
                "connection": "keep-alive",
                "x-amzn-requestid": "9d31dde9-a924-4526-b8b4-0bb691eb11c3"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Unknown\"\n}\n``` \n\n**Explanation:**  \n- **Diagnosis:** \"RASopathy\" was replaced with \"Noonan Syndrome\" (a specific RASopathy disorder in the target schema)  \n- **Assay:** \"immunoassay\" already matches the exact controlled terminology  \n- **TumorType:** \"NFIB\" (not in target schema) was mapped to \"Unknown\" since no valid narrower term exists in the controlled vocabulary"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace any broad terms with the more specific ones from the Target Schema.\n\nFirst, the diagnosis is \"RASopathy\". Looking at the Target Schema's diagnosis enum, I don't see \"RASopathy\" listed. However, I know that Noonan Syndrome is a type of RASopathy. So, replacing \"RASopathy\" with \"Noonan Syndrome\" makes sense here. That's one of the allowed values, so that's a good substitution.\n\nNext, the assay is \"immunoassay\". Checking the assay enum, \"immunoassay\" is actually present. So no changes needed here. It's already using the exact term from the schema.\n\nThen, the tumorType is \"NFIB\". The Target Schema's tumorType enum doesn't have \"NFIB\". I need to think about what \"NFIB\" refers to. NFIB is a gene, but in the context of tumor types, maybe it's a typo or abbreviation. Looking at the options, \"NF1-Associated Tumor\" or \"NF2-Associated Tumor\" might be relevant. Since the diagnosis was RASopathy (now Noonan Syndrome), but the original input's tumorType is \"NFIB\", which isn't in the schema. Since \"NFIB\" isn't listed, the safest choice from the enum is \"Unknown\" because there's no direct match. Alternatively, if \"NFIB\" is a specific tumor type not listed, but according to the schema, \"Unknown\" is an option. So I'll go with \"Unknown\" for tumorType.\n\nWait, but maybe \"NFIB\" is a type of neurofibroma? Let me check the tumorType enum again. There's \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", etc. But \"NFIB\" isn't there. So unless \"NFIB\" is a known abbreviation for one of the listed types, which I don't think it is, \"Unknown\" is the correct choice here.\n\nSo the corrected metadata would be:\n- diagnosis: \"Noonan Syndrome\"\n- assay: remains \"immunoassay\"\n- tumorType: \"Unknown\"\n\nI need to make sure all replacements are exact matches from the Target Schema. Since \"Noonan Syndrome\" and \"Unknown\" are in the enums, and \"immunoassay\" is already correct, this should be the right answer.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2316,
              "outputTokens": 632,
              "totalTokens": 2948
            },
            "metrics": {
              "latencyMs": 4317
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2316,
          "output_tokens": 632,
          "total_tokens": 2948
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```Okay, let's tackle this metadata correction task. The user wants me to narrow broad synonyms in the input data using the exact terms from the Target Schema.\n\nFirst, looking at the diagnosis field. The input is \"NF\". In the Target Schema's diagnosis enum, there's \"Neurofibromatosis type 1\". \"NF\" is a common abbreviation for Neurofibromatosis, so replacing \"NF\" with \"Neurofibromatosis type 1\" makes sense here. I need to check if there are other possible matches, but \"NF\" is most likely referring to type 1 since there's no other NF-related term except \"NF2-related schwannomatosis\", but the input is just \"NF\", so type 1 is the safe choice.\n\nNext, the assay field has \"medical imaging\". The Target Schema's assay enum includes \"conventional MRI\", \"structural MRI\", \"ultrasound\", etc. \"Medical imaging\" is a broad term. The closest specific term here would be \"conventional MRI\" as it's a common medical imaging technique. But wait, there's also \"ultrasound\" and others. However, \"medical imaging\" is too general. Since the schema doesn't have a more general term, but \"conventional MRI\" is a type of medical imaging, maybe that's the best fit. Alternatively, \"structural MRI\" could be another option. But the user said to use exact terms. Let me check the enum again. The assay enum includes \"conventional MRI\" and \"structural MRI\". Since \"medical imaging\" is a broad term, and the user wants the most specific, perhaps \"conventional MRI\" is the correct choice here. Alternatively, if the original context is about MRI, but without more info, \"conventional MRI\" is a safe narrowing.\n\nFor tumorType, the input is \"unknown\". The Target Schema's tumorType enum has \"Unknown\" (with a capital U). The input is lowercase, but the schema expects exact values, so it should be corrected to \"Unknown\" to match the enum exactly.\n\nSo the corrected JSON should be:\n\ndiagnosis: \"Neurofibromatosis type 1\"\nassay: \"conventional MRI\"\ntumorType: \"Unknown\"\n\nI need to make sure all replacements are exact terms from the schema. Let me double-check each enum list again.\n\nDiagnosis: Yes, \"Neurofibromatosis type 1\" is in the list.\n\nAssay: \"conventional MRI\" is in the assay enum under \"conventional MRI\".\n\nTumorType: \"Unknown\" is present.\n\nLooks good. No other terms fit better. So the final answer should reflect these changes.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2312,
            "outputTokens": 586,
            "totalTokens": 2898
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "48b86124-2bfc-4e7a-9f85-d217484956b5",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:37 GMT",
                "content-type": "application/json",
                "content-length": "2797",
                "connection": "keep-alive",
                "x-amzn-requestid": "48b86124-2bfc-4e7a-9f85-d217484956b5"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The user wants me to narrow broad synonyms in the input data using the exact terms from the Target Schema.\n\nFirst, looking at the diagnosis field. The input is \"NF\". In the Target Schema's diagnosis enum, there's \"Neurofibromatosis type 1\". \"NF\" is a common abbreviation for Neurofibromatosis, so replacing \"NF\" with \"Neurofibromatosis type 1\" makes sense here. I need to check if there are other possible matches, but \"NF\" is most likely referring to type 1 since there's no other NF-related term except \"NF2-related schwannomatosis\", but the input is just \"NF\", so type 1 is the safe choice.\n\nNext, the assay field has \"medical imaging\". The Target Schema's assay enum includes \"conventional MRI\", \"structural MRI\", \"ultrasound\", etc. \"Medical imaging\" is a broad term. The closest specific term here would be \"conventional MRI\" as it's a common medical imaging technique. But wait, there's also \"ultrasound\" and others. However, \"medical imaging\" is too general. Since the schema doesn't have a more general term, but \"conventional MRI\" is a type of medical imaging, maybe that's the best fit. Alternatively, \"structural MRI\" could be another option. But the user said to use exact terms. Let me check the enum again. The assay enum includes \"conventional MRI\" and \"structural MRI\". Since \"medical imaging\" is a broad term, and the user wants the most specific, perhaps \"conventional MRI\" is the correct choice here. Alternatively, if the original context is about MRI, but without more info, \"conventional MRI\" is a safe narrowing.\n\nFor tumorType, the input is \"unknown\". The Target Schema's tumorType enum has \"Unknown\" (with a capital U). The input is lowercase, but the schema expects exact values, so it should be corrected to \"Unknown\" to match the enum exactly.\n\nSo the corrected JSON should be:\n\ndiagnosis: \"Neurofibromatosis type 1\"\nassay: \"conventional MRI\"\ntumorType: \"Unknown\"\n\nI need to make sure all replacements are exact terms from the schema. Let me double-check each enum list again.\n\nDiagnosis: Yes, \"Neurofibromatosis type 1\" is in the list.\n\nAssay: \"conventional MRI\" is in the assay enum under \"conventional MRI\".\n\nTumorType: \"Unknown\" is present.\n\nLooks good. No other terms fit better. So the final answer should reflect these changes.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2312,
              "outputTokens": 586,
              "totalTokens": 2898
            },
            "metrics": {
              "latencyMs": 4013
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2312,
          "output_tokens": 586,
          "total_tokens": 2898
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation:**\n- Diagnosis: \"neurocristopathy\" was mapped to \"Schwannomatosis-NOS\" (Not Otherwise Specified) since schwannomatosis is a type of neurocristopathy and no more specific subtype was indicated\n- Assay: \"transcriptomics\" was already an exact match in the controlled terminology\n- TumorType: \"neurolemmoma\" was mapped to \"Schwannoma\" (exact synonym per medical terminology)Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms to more specific terms using the provided Target Schema.\n\nFirst, looking at the \"diagnosis\" field. The input is \"neurocristopathy\". I need to check if this term exists in the Target Schema's enum for diagnosis. Scanning through the list, I don't see \"neurocristopathy\" there. However, I know that schwannomatosis is a type of neurocristopathy. The closest terms in the schema are \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified). Since there's no specific subtype mentioned, \"Schwannomatosis-NOS\" seems appropriate here.\n\nNext, the \"assay\" field is \"transcriptomics\". The Target Schema's assay enum includes \"transcriptomics\" as an exact match. So no change needed here. That's straightforward.\n\nNow, the \"tumorType\" is \"neurolemmoma\". I recall that neurolemmoma is another name for schwannoma. Checking the tumorType enum, \"Schwannoma\" is listed. So replacing \"neurolemmoma\" with \"Schwannoma\" makes sense.\n\nI need to ensure all replacements use the exact terms from the schema. No variations allowed. Let me double-check each enum list again to confirm. Yes, \"Schwannomatosis-NOS\" is in diagnosis, \"transcriptomics\" is correct, and \"Schwannoma\" is in tumorType. Everything looks good. The final JSON should reflect these changes accurately.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2319,
            "outputTokens": 484,
            "totalTokens": 2803
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "36e48e47-63f6-44d1-98ad-06316033862b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:40 GMT",
                "content-type": "application/json",
                "content-length": "2227",
                "connection": "keep-alive",
                "x-amzn-requestid": "36e48e47-63f6-44d1-98ad-06316033862b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation:**\n- Diagnosis: \"neurocristopathy\" was mapped to \"Schwannomatosis-NOS\" (Not Otherwise Specified) since schwannomatosis is a type of neurocristopathy and no more specific subtype was indicated\n- Assay: \"transcriptomics\" was already an exact match in the controlled terminology\n- TumorType: \"neurolemmoma\" was mapped to \"Schwannoma\" (exact synonym per medical terminology)"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction task. The user wants me to narrow down broad synonyms to more specific terms using the provided Target Schema.\n\nFirst, looking at the \"diagnosis\" field. The input is \"neurocristopathy\". I need to check if this term exists in the Target Schema's enum for diagnosis. Scanning through the list, I don't see \"neurocristopathy\" there. However, I know that schwannomatosis is a type of neurocristopathy. The closest terms in the schema are \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified). Since there's no specific subtype mentioned, \"Schwannomatosis-NOS\" seems appropriate here.\n\nNext, the \"assay\" field is \"transcriptomics\". The Target Schema's assay enum includes \"transcriptomics\" as an exact match. So no change needed here. That's straightforward.\n\nNow, the \"tumorType\" is \"neurolemmoma\". I recall that neurolemmoma is another name for schwannoma. Checking the tumorType enum, \"Schwannoma\" is listed. So replacing \"neurolemmoma\" with \"Schwannoma\" makes sense.\n\nI need to ensure all replacements use the exact terms from the schema. No variations allowed. Let me double-check each enum list again to confirm. Yes, \"Schwannomatosis-NOS\" is in diagnosis, \"transcriptomics\" is correct, and \"Schwannoma\" is in tumorType. Everything looks good. The final JSON should reflect these changes accurately.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2319,
              "outputTokens": 484,
              "totalTokens": 2803
            },
            "metrics": {
              "latencyMs": 3010
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2319,
          "output_tokens": 484,
          "total_tokens": 2803
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```Okay, let's tackle this metadata correction step by step. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace the broad terms with the specific ones from the Target Schema.\n\nFirst, the diagnosis is \"phakomatosis\". I know that phakomatosis is a general term for a group of neurocutaneous disorders, which includes conditions like neurofibromatosis and schwannomatosis. Looking at the Target Schema's diagnosis enum, the closest specific terms are \"Neurofibromatosis type 1\" and various schwannomatosis-related terms. Since \"phakomatosis\" is too broad and the schema doesn't include that exact term, I need to pick the most appropriate specific diagnosis. However, without more context, it's tricky. But given common associations, \"Neurofibromatosis type 1\" might be a possible replacement. Wait, but the input might actually be a schwannomatosis case. Alternatively, maybe \"Schwannomatosis-NOS\" (Not Otherwise Specified) if it's a schwannomatosis but not further classified. But the original term is \"phakomatosis\", which is even broader. Hmm. The schema doesn't have a direct equivalent, so maybe \"Schwannomatosis-NOS\" isn't right. Alternatively, perhaps \"Not Applicable\" or \"Unknown\"? Wait, but \"phakomatosis\" is a valid term, just too broad. The Target Schema doesn't include it, so maybe the correct approach is to map it to a more specific term under the schema. Since the schema includes \"Neurofibromatosis type 1\" and schwannomatosis types, but the input is \"phakomatosis\", which is a category that includes these, perhaps the correct replacement isn't directly available. But the user's instruction says to narrow broad synonyms. Maybe in this context, \"phakomatosis\" is being used as a synonym for a specific condition. For example, sometimes \"phakomatosis\" is used interchangeably with neurofibromatosis. But without more context, it's a bit of a guess. Alternatively, if the original data is about schwannomatosis, then one of the schwannomatosis terms would be appropriate. But since the input is \"phakomatosis\", which is broader, and the Target Schema doesn't have that term, perhaps the correct answer is to use \"Schwannomatosis-NOS\" or \"Neurofibromatosis type 1\". But I need to check if \"phakomatosis\" is a known synonym for any of the terms in the Target Schema. For example, Neurofibromatosis type 1 is part of the phakomatoses. So maybe the correct mapping is \"Neurofibromatosis type 1\". However, without additional context, it's hard to be certain. Alternatively, if the original data is related to schwannomas, then a schwannomatosis term would be better. But given the ambiguity, perhaps the safest choice is to use \"Schwannomatosis-NOS\" as a more specific term under the broader phakomatosis category. Wait, but the Target Schema has \"Schwannomatosis\" as an enum value. So maybe \"Schwannomatosis\" is the correct replacement. But I need to confirm. Phakomatosis includes conditions like NF1, NF2, tuberous sclerosis, etc. If the original diagnosis is phakomatosis, but the Target Schema doesn't have that term, we need to pick the most specific possible. However, since the schema doesn't include phakomatosis, and the user wants to narrow it, perhaps the correct approach is to map it to a more specific term. But without knowing the exact condition, maybe \"Schwannomatosis-NOS\" is the best fit. Alternatively, if the tumorType is \"tumor of cranial and spinal nerves\", which are locations where schwannomas occur, then the diagnosis might be schwannomatosis. So perhaps \"Schwannomatosis\" is the correct diagnosis here.\n\nNext, the assay is \"viability assay\". The Target Schema has \"cell viability assay\" as an enum option. So replacing \"viability assay\" with \"cell viability assay\" makes sense here.\n\nFor tumorType, the input is \"tumor of cranial and spinal nerves\". The Target Schema's tumorType enum includes \"Schwannoma\", which is a tumor of the nerve sheath, typically arising from Schwann cells. Cranial and spinal nerves are common sites for schwannomas. So replacing \"tumor of cranial and spinal nerves\" with \"Schwannoma\" is appropriate.\n\nSo putting it all together:\n\nDiagnosis: \"phakomatosis\" \u2192 \"Schwannomatosis\" (assuming the context points to schwannomatosis based on tumorType being schwannoma)\n\nAssay: \"viability assay\" \u2192 \"cell viability assay\"\n\nTumorType: \"tumor of cranial and spinal nerves\" \u2192 \"Schwannoma\"\n\nI need to ensure that all replacements are exact matches from the Target Schema. Let me double-check the enums:\n\nDiagnosis enum includes \"Schwannomatosis\", which is an exact term. So that's correct.\n\nAssay enum has \"cell viability assay\" \u2013 yes.\n\nTumorType enum has \"Schwannoma\" \u2013 correct.\n\nTherefore, the corrected metadata should have those values.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2322,
            "outputTokens": 1163,
            "totalTokens": 3485
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "eea7be2a-f1c8-47ec-859d-5acb56e2e7e9",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:38:47 GMT",
                "content-type": "application/json",
                "content-length": "5253",
                "connection": "keep-alive",
                "x-amzn-requestid": "eea7be2a-f1c8-47ec-859d-5acb56e2e7e9"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata correction step by step. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace the broad terms with the specific ones from the Target Schema.\n\nFirst, the diagnosis is \"phakomatosis\". I know that phakomatosis is a general term for a group of neurocutaneous disorders, which includes conditions like neurofibromatosis and schwannomatosis. Looking at the Target Schema's diagnosis enum, the closest specific terms are \"Neurofibromatosis type 1\" and various schwannomatosis-related terms. Since \"phakomatosis\" is too broad and the schema doesn't include that exact term, I need to pick the most appropriate specific diagnosis. However, without more context, it's tricky. But given common associations, \"Neurofibromatosis type 1\" might be a possible replacement. Wait, but the input might actually be a schwannomatosis case. Alternatively, maybe \"Schwannomatosis-NOS\" (Not Otherwise Specified) if it's a schwannomatosis but not further classified. But the original term is \"phakomatosis\", which is even broader. Hmm. The schema doesn't have a direct equivalent, so maybe \"Schwannomatosis-NOS\" isn't right. Alternatively, perhaps \"Not Applicable\" or \"Unknown\"? Wait, but \"phakomatosis\" is a valid term, just too broad. The Target Schema doesn't include it, so maybe the correct approach is to map it to a more specific term under the schema. Since the schema includes \"Neurofibromatosis type 1\" and schwannomatosis types, but the input is \"phakomatosis\", which is a category that includes these, perhaps the correct replacement isn't directly available. But the user's instruction says to narrow broad synonyms. Maybe in this context, \"phakomatosis\" is being used as a synonym for a specific condition. For example, sometimes \"phakomatosis\" is used interchangeably with neurofibromatosis. But without more context, it's a bit of a guess. Alternatively, if the original data is about schwannomatosis, then one of the schwannomatosis terms would be appropriate. But since the input is \"phakomatosis\", which is broader, and the Target Schema doesn't have that term, perhaps the correct answer is to use \"Schwannomatosis-NOS\" or \"Neurofibromatosis type 1\". But I need to check if \"phakomatosis\" is a known synonym for any of the terms in the Target Schema. For example, Neurofibromatosis type 1 is part of the phakomatoses. So maybe the correct mapping is \"Neurofibromatosis type 1\". However, without additional context, it's hard to be certain. Alternatively, if the original data is related to schwannomas, then a schwannomatosis term would be better. But given the ambiguity, perhaps the safest choice is to use \"Schwannomatosis-NOS\" as a more specific term under the broader phakomatosis category. Wait, but the Target Schema has \"Schwannomatosis\" as an enum value. So maybe \"Schwannomatosis\" is the correct replacement. But I need to confirm. Phakomatosis includes conditions like NF1, NF2, tuberous sclerosis, etc. If the original diagnosis is phakomatosis, but the Target Schema doesn't have that term, we need to pick the most specific possible. However, since the schema doesn't include phakomatosis, and the user wants to narrow it, perhaps the correct approach is to map it to a more specific term. But without knowing the exact condition, maybe \"Schwannomatosis-NOS\" is the best fit. Alternatively, if the tumorType is \"tumor of cranial and spinal nerves\", which are locations where schwannomas occur, then the diagnosis might be schwannomatosis. So perhaps \"Schwannomatosis\" is the correct diagnosis here.\n\nNext, the assay is \"viability assay\". The Target Schema has \"cell viability assay\" as an enum option. So replacing \"viability assay\" with \"cell viability assay\" makes sense here.\n\nFor tumorType, the input is \"tumor of cranial and spinal nerves\". The Target Schema's tumorType enum includes \"Schwannoma\", which is a tumor of the nerve sheath, typically arising from Schwann cells. Cranial and spinal nerves are common sites for schwannomas. So replacing \"tumor of cranial and spinal nerves\" with \"Schwannoma\" is appropriate.\n\nSo putting it all together:\n\nDiagnosis: \"phakomatosis\" \u2192 \"Schwannomatosis\" (assuming the context points to schwannomatosis based on tumorType being schwannoma)\n\nAssay: \"viability assay\" \u2192 \"cell viability assay\"\n\nTumorType: \"tumor of cranial and spinal nerves\" \u2192 \"Schwannoma\"\n\nI need to ensure that all replacements are exact matches from the Target Schema. Let me double-check the enums:\n\nDiagnosis enum includes \"Schwannomatosis\", which is an exact term. So that's correct.\n\nAssay enum has \"cell viability assay\" \u2013 yes.\n\nTumorType enum has \"Schwannoma\" \u2013 correct.\n\nTherefore, the corrected metadata should have those values.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2322,
              "outputTokens": 1163,
              "totalTokens": 3485
            },
            "metrics": {
              "latencyMs": 6914
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2322,
          "output_tokens": 1163,
          "total_tokens": 3485
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 55.0418496131897,
    "token_usage": {
      "input_tokens": 23177,
      "output_tokens": 8800,
      "total_tokens": 31977
    }
  }
}